Kezar Life Sciences Puts Zetomipzomib IND for Lupus Nephritis on Clinical Hold
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology firm focused on developing innovative small molecules for immune-mediated diseases, has announced that its Investigational New Drug (IND) application for zetomipzomib,…